|
![]() |
Tolterodine tartrateThis page contains recent news articles, when available, and an overview of Tolterodine tartrate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Drug therapy consisted of tolterodine tartrate 4 mg/day for both groups. Drug adherence was monitored by pill count and behavioral adherence by Medscape (subscription) Pharmaceutical Polymorphs & Patent Strategy - May 21, 2008 The latest that I am aware of is Hetero's tolterodine tartrate (Detrol) polymorph patent application US 20050131067, which has been allowed with a claim 1 Mondaq News Alerts (subscription), UPDATE: Pfizer Sues Impax Over Generic Version Of Detrol LA - Mar 5, 2008 Pfizer sells tolterodine tartrate extended-release capsules in two-milligram and four-milligram dosages under the name Detrol LA, according to the lawsuit. CNNMoney.com Pfizer sues Impax for infringing Detrol patents - Mar 5, 2008 In a lawsuit filed on Tuesday, Pfizer said Impax was seeking US Food and Drug Administration approval to market tolterodine tartrate extended release Reuters Tolterodine Extended-Release Does Not Impair Memory In Patients ... - Dec 1, 2006 Medical News Today,CHRISTCHURCH, NEW ZEALAND - Tolterodine tartrate extended-release or ER (Detrol LAR), 4 mg per day, does not affect recent memory in healthy older patients Blood pressure and bladder drugs mix 11 Apr 2006 ...control. Now her doctor wants to prescribe Detrol LA (tolterodine tartrate) for her overactive bladder. Is this combination safe? ... - Newsday : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |